Pregnancy is an important phase of life, and early prenatal screening helps assess fetal well-being in a safe and non-invasive manner. The Double Marker Test is a commonly used first-trimester screening test and forms an integral part of the First-Trimester Combined Screening protocol.

What is the Double Marker Test?

The Double Marker Test is a maternal blood test performed during early pregnancy to assess the risk of specific chromosomal abnormalities in the fetus. It is a screening test and not a diagnostic test.

The test measures two placental biomarkers in maternal blood:

• Free beta-human chorionic gonadotropin (free β-hCG)
• Pregnancy-Associated Plasma Protein-A (PAPP-A)

The results are interpreted in combination with:

• Maternal age
• Gestational age
• Maternal weight and demographic factors
• Nuchal Translucency (NT) ultrasound findings 

When is the Double Marker Test Done?

• Blood sample collection: between 9 weeks 0 days and 13 weeks 6 days of pregnancy
• NT scan: between 11 weeks 0 days and 13 weeks 6 days (CRL 45–84 mm)

Both are usually done in tandem at the time of NT scan. Risk assessment is completed after combining biochemical and ultrasound data.

Why is the Double Marker Test Important?

Early Risk Assessment:

• Screens for Down syndrome (Trisomy 21)
• Screens for Edwards syndrome (Trisomy 18)

Personalised Pregnancy Care:

• Helps stratify pregnancies into low, intermediate and high-risk categories
• Guides the need for further screening or diagnostic testing

Reduction of Unnecessary Invasive Testing:

• Most women receive low-risk results and can avoid invasive procedures 

How is the Test Performed?

Step 1 – Blood Sample Collection:
A small sample of blood is drawn from the mother’s arm. No fasting is required.

Step 2 – Laboratory Analysis:
Levels of free β-hCG and PAPP-A are measured and converted to Multiples of the Median (MoM).

Step 3 – Integration with NT Scan:
Biochemical results are combined with NT measurement and maternal factors using validated software.

Step 4 – Report Generation:
The final report provides a risk estimate for chromosomal abnormalities. 

Understanding Test Results

Low-Risk Result:
Indicates a reduced probability of chromosomal abnormalities but does not completely exclude them.

High-Risk Result:
Indicates an increased probability. This does not confirm a diagnosis. Further testing such as NIPT, CVS, or amniocentesis may be advised. 

What Does the Risk Ratio Means?

Risk is expressed as a ratio (for example, 1 in 1,000 or 1 in 50). A result of 1 in 100 indicates a 1% probability of the condition being present and is considered high risk. A risk below 1:1000 is considered low risk.

Important Note on Normal Values

Double Marker Test biochemical results do not have absolute normal ranges. Results are interpreted only as Multiples of the Median (MoM), adjusted for:

• Gestational age
• Maternal age and weight
• Ethnicity
• Smoking status
• Mode of conception 

Factors Affecting Test Accuracy

• Accurate dating of pregnancy
• Maternal age
• Maternal weight
• Multiple pregnancy
• Assisted reproductive techniques (IVF)
• Timing of blood sampling and NT scan

Double Marker Test in Twin Pregnancy

In twin pregnancies, serum marker interpretation is limited but can be done. Risk assessment relies primarily on NT measurement and chorionicity.
Individualised counselling is essential. 

How Accurate is the Test?

When combined with good NT scan :

• Detection rate for Down syndrome: approximately 90-95%
• False-positive rate: approximately 5%

The test remains a screening test and is not diagnostic. 

Double Marker Test vs NIPT

Double Marker Test:
• First-trimester screening
• Lower cost
• Moderate detection rate

NIPT:
• Cell-free fetal DNA test
• Higher accuracy (>99% for Trisomy 21)
• Still a screening test, not diagnostic

Is the Double Marker Test Safe?

Yes. The test is non-invasive and poses no risk to the mother or fetus. 

Mandatory Disclaimer

The Double Marker Test is a screening test, not a diagnostic test. A high-risk result does not confirm a chromosomal abnormality. Diagnostic procedures such as CVS or amniocentesis are required for confirmation. 

Short Summary

The Double Marker Test is a first-trimester blood screening test performed between 9 and 13+6 weeks of pregnancy. It forms part of the First-Trimester Combined Screening when interpreted along with a nuchal translucency (NT) ultrasound and maternal factors. The test assesses the risk of common chromosomal conditions such as Down syndrome (Trisomy 21) and Edwards syndrome (Trisomy 18). It is a screening test, not a diagnostic test, and helps guide further prenatal care and testing decisions. 

Frequently Asked Questions

Is the Double Marker Test compulsory?
No. It is optional but recommended as part of first-trimester screening.

Do I need to fast before the test?
No fasting is required.

Does a low-risk result guarantee a normal baby?
No. It significantly reduces risk but does not eliminate it completely.

What happens if my result is high risk?
Your doctor will discuss further screening or diagnostic options.

Can I choose NIPT instead of Double Marker?
Yes. This can be decided after counselling.